Table 3.
Secondary Outcomes Results
| Secondary Endpoints (N=34) | Pharmacist Care (n=17) | Primary Care Provider Group (n=17) | P-Value |
|---|---|---|---|
|
Number of hospitalizations, n VTE-related, n |
5 1 |
3 1 |
0.688 1.000 |
| Thromboembolic event, n (%) | 1 (6%) | 1 (6%) | 1.000 |
| Fatality due to thromboembolism or bleeding, n (%) | 0 (0%) | 0 (0%) | 1.000 |
| Major bleeding, n (%) | 0 (0%) | 0 (0%) | 1.000 |
| Adverse events, n (%) | 7 (41%) | 4 (24%) | 0.465 |
| Formal medication adherence evaluation performed, n (%) | 8 (47%) | 0 (0%) | 0.003 |
a
Morisky Adherence Questionnaire score ranges from 0–8. A score of 0 indicates high adherence. A score of 1–2 indicates medium adherence. A score of >2 indicates low adherence.10